Eiger Biopharmaceuticals Inc Asset Turnover Ratio (EIGR), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eiger Biopharmaceuticals Inc   (NASDAQ: EIGR)
 

Eiger Biopharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Eiger Biopharmaceuticals Inc asset turnover ratio, the ability of Eiger Biopharmaceuticals Inc 's assets to generate revenue in the fourth quarter 2023, increased sequentially to 0.24 in the fourth quarter (Dec 31 2023), yet the ratio remained below the average, as EIGR's position remain challenging.

Within sector 33 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 2539 to 2559.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EIGR Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -67.68 % -61.28 % -55.8 % -35.28 % -4.95 %
Y / Y Revenue Change 41.06 % -20.25 % 13.49 % 54.06 % -19.76 %
Asset Turnover Ratio (TTM) 0.24 0.17 0.14 0.11 0.09
EIGR's Total Ranking # 2559 # 2539 # 2170 # 2425 # 2500
Seq. Asset Change -30.24 % -23.09 % -27.08 % -17.41 % -16.42 %
Seq. Revenue Change 18.51 % -30.89 % 12.75 % 52.74 % -33 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 34
Healthcare Sector # 325
Overall Market # 2559

Asset Turnover Ratio Statistics
High Average Low
7.16 6.08 4.93
(Dec 31 2022)   (Mar 31 2022)




EIGR Company Profile • Back to EIGR Efficiency Comparisons • Compare EIGR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Scynexis Inc   1.12 $ 140.141  Millions$ 125.527  Millions
Amedisys Inc  1.12 $ 2,236.382  Millions$ 2,004.237  Millions
Vaso Corporation  1.11 $ 81.323  Millions$ 72.967  Millions
Dynatronics Corporation  1.11 $ 34.097  Millions$ 30.787  Millions
Lftd Partners Inc   1.10 $ 51.611  Millions$ 46.884  Millions
Lifeloc Technologies Inc   1.10 $ 9.330  Millions$ 8.493  Millions
Acadia Pharmaceuticals Inc   1.08 $ 726.437  Millions$ 669.893  Millions
Yunhong Green Cti Ltd   1.08 $ 17.258  Millions$ 15.927  Millions
Addus Homecare Corp  1.08 $ 1,057.876  Millions$ 979.905  Millions
Aspira Women s Health inc   1.07 $ 9.154  Millions$ 8.535  Millions
Healthlynked Corp  1.06 $ 5.722  Millions$ 5.410  Millions
Talkspace Inc   1.05 $ 149.380  Millions$ 141.968  Millions
Eton Pharmaceuticals Inc   1.05 $ 31.061  Millions$ 29.531  Millions
Theratechnologies Inc   1.05 $ 81.764  Millions$ 77.769  Millions
The Pennant Group Inc   1.05 $ 544.891  Millions$ 520.894  Millions
Universal Health Services Inc   1.04 $ 14,281.976  Millions$ 13,782.335  Millions
Precision Optics Corporation Inc   1.03 $ 19.218  Millions$ 18.673  Millions
Journey Medical Corp  1.03 $ 79.181  Millions$ 77.092  Millions
Sanuwave Health Inc   1.03 $ 20.397  Millions$ 19.863  Millions
Vivos Therapeutics Inc   1.02 $ 13.271  Millions$ 12.974  Millions
Phibro Animal Health Corporation  1.01 $ 980.412  Millions$ 968.187  Millions
Bionexus Gene Lab Corp   1.00 $ 9.771  Millions$ 9.738  Millions
Ufp Technologies Inc   1.00 $ 399.225  Millions$ 398.180  Millions
Stablecoin Development Corporation  1.00 $ 13.210  Millions$ 13.180  Millions
Prosomnus Inc   1.00 $ 27.652  Millions$ 27.620  Millions
Inspire Medical Systems inc   1.00 $ 624.223  Millions$ 626.600  Millions
Avricore Health Inc   0.99 $ 1.922  Millions$ 1.944  Millions
Rigel Pharmaceuticals Inc  0.99 $ 116.882  Millions$ 118.313  Millions
Tactile Systems Technology Inc   0.98 $ 274.133  Millions$ 280.994  Millions
Marpai Inc  0.97 $ 37.155  Millions$ 38.310  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.